Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Neuropharmacology
  4. Volume 23, Issue 5
  5. Article
Volume 23, Issue 5
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Neurodegenerative diseases (NDDs) are a multifaceted and heterogeneous group of complex diseases. Unfortunately, a cure for these conditions has yet to be found, but there are ways to reduce the risk of developing them. Studies have shown that specific vitamins regulate the brain molecules and signaling pathways, which may help prevent degeneration. This review focuses on examining the role of vitamins in preventing five significant types of neurodegenerative diseases, including Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). This review also highlights promising and controversial findings about the potential impact of vitamins on this group of diseases. Several developed countries standardize daily dietary vitamin intake to meet nutrient requirements, improve health, and prevent chronic diseases like NDDs. However, more research is necessary to gain a more comprehensive understanding of their therapeutic benefits, including studies exploring different drug-dose paradigms, diverse humanized animal models, and clinical trials conducted in various locations.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X327677240902105443
2024-11-21
2025-04-11

  • From This Site

    /content/journals/cn/10.2174/011570159X327677240902105443
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ShenkinA. Micronutrients in health and disease.Postgrad Med J2006829715596710.1136/pgmj.2006.047670
     [Google Scholar]
  2. Lahoda BrodskaH. KlempirJ. ZavoraJ. KohoutP. The role of micronutrients in neurological disorders.Nutrients20231519412910.3390/nu15194129
     [Google Scholar]
  3. KumarR.R. SinghL. ThakurA. SinghS. KumarB. Role of vitamins in neurodegenerative diseases: A review.CNS Neurol. Disord. Drug Targets202221976677310.2174/187152732066621111912215034802410
     [Google Scholar]
  4. RaiS.N. SinghP. SteinbuschH.W.M. VamanuE. AshrafG. SinghM.P. The role of vitamins in neurodegenerative disease: An update.Biomedicines.2021910128410.3390/biomedicines9101284
     [Google Scholar]
  5. ŠeperV. NešićN. Nutrition patterns in prevention and treatment of neurodegenerative diseases: Alzheimer’s disease.Eur. Med. J.2019314249
     [Google Scholar]
  6. NicholsE. SteinmetzJ.D. VollsetS.E. FukutakiK. ChalekJ. Abd-AllahF. AbdoliA. AbualhasanA. Abu-GharbiehE. AkramT.T. Al HamadH. AlahdabF. AlaneziF.M. AlipourV. AlmustanyirS. AmuH. AnsariI. ArablooJ. AshrafT. Astell-BurtT. AyanoG. Ayuso-MateosJ.L. BaigA.A. BarnettA. BarrowA. BauneB.T. BéjotY. BezabheW.M.M. BezabihY.M. BhagavathulaA.S. BhaskarS. BhattacharyyaK. BijaniA. BiswasA. BollaS.R. BoloorA. BrayneC. BrennerH. BurkartK. BurnsR.A. CámeraL.A. CaoC. CarvalhoF. Castro-de-AraujoL.F.S. Catalá-LópezF. CerinE. ChavanP.P. CherbuinN. ChuD-T. CostaV.M. CoutoR.A.S. DadrasO. DaiX. DandonaL. DandonaR. De la Cruz-GóngoraV. DhamnetiyaD. Dias da SilvaD. DiazD. DouiriA. EdvardssonD. EkholuenetaleM. El SayedI. El-JaafaryS.I. EskandariK. EskandariehS. EsmaeilnejadS. FaresJ. FaroA. FarooqueU. FeiginV.L. FengX. FereshtehnejadS-M. FernandesE. FerraraP. FilipI. FillitH. FischerF. GaidhaneS. GalluzzoL. GhashghaeeA. GhithN. GialluisiA. GilaniS.A. GlavanI-R. GnedovskayaE.V. GolechhaM. GuptaR. GuptaV.B. GuptaV.K. HaiderM.R. HallB.J. HamidiS. HanifA. HankeyG.J. HaqueS. HartonoR.K. HasaballahA.I. HasanM.T. HassanA. HayS.I. HayatK. HegazyM.I. HeidariG. Heidari-SoureshjaniR. HerteliuC. HousehM. HussainR. HwangB-F. IacovielloL. IavicoliI. IlesanmiO.S. IlicI.M. IlicM.D. IrvaniS.S.N. IsoH. IwagamiM. JabbarinejadR. JacobL. JainV. JayapalS.K. JayawardenaR. JhaR.P. JonasJ.B. JosephN. KalaniR. KandelA. KandelH. KarchA. KasaA.S. KassieG.M. KeshavarzP. KhanM.A.B. KhatibM.N. KhojaT.A.M. KhubchandaniJ. KimM.S. KimY.J. KisaA. KisaS. KivimäkiM. KoroshetzW.J. KoyanagiA. KumarG.A. KumarM. LakH.M. LeonardiM. LiB. LimS.S. LiuX. LiuY. LogroscinoG. LorkowskiS. LucchettiG. Lutzky SauteR. MagnaniF.G. MalikA.A. MassanoJ. MehndirattaM.M. MenezesR.G. MeretojaA. MohajerB. Mohamed IbrahimN. MohammadY. MohammedA. MokdadA.H. MondelloS. MoniM.A.A. MoniruzzamanM. MossieT.B. NagelG. NaveedM. NayakV.C. Neupane KandelS. NguyenT.H. OanceaB. OtstavnovN. OtstavnovS.S. OwolabiM.O. Panda-JonasS. Pashazadeh KanF. PasovicM. PatelU.K. PathakM. PeresM.F.P. PerianayagamA. PetersonC.B. PhillipsM.R. PinheiroM. PiradovM.A. PondC.D. PotashmanM.H. PottooF.H. PradaS.I. RadfarA. RaggiA. RahimF. RahmanM. RamP. RanasingheP. RawafD.L. RawafS. RezaeiN. RezapourA. RobinsonS.R. RomoliM. RoshandelG. SahathevanR. SahebkarA. SahraianM.A. SathianB. SattinD. SawhneyM. SaylanM. SchiavolinS. SeylaniA. ShaF. ShaikhM.A. ShajiK.S. ShannawazM. ShettyJ.K. ShigematsuM. ShinJ.I. ShiriR. SilvaD.A.S. SilvaJ.P. SilvaR. SinghJ.A. SkryabinV.Y. SkryabinaA.A. SmithA.E. SoshnikovS. SpurlockE.E. SteinD.J. SunJ. Tabarés-SeisdedosR. ThakurB. TimalsinaB. Tovani-PaloneM.R. TranB.X. TsegayeG.W. Valadan TahbazS. ValdezP.R. VenketasubramanianN. VlassovV. VuG.T. VuL.G. WangY-P. WimoA. WinklerA.S. YadavL. Yahyazadeh JabbariS.H. YamagishiK. YangL. YanoY. YonemotoN. YuC. YunusaI. ZadeyS. ZastrozhinM.S. ZastrozhinaA. ZhangZ-J. MurrayC.J.L. VosT. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the global burden of disease study 2019.Lancet Public Health202272e105e12510.1016/S2468‑2667(21)00249‑834998485
     [Google Scholar]
  7. BusinaroR. VauzourD. SarrisJ. MünchG. GyengesiE. BrogelliL. ZuzarteP. Therapeutic opportunities for food supplements in neurodegenerative disease and depression.Front Nutr.2021866984610.3389/fnut.2021.669846
     [Google Scholar]
  8. SherzaiA.Z. TagliatiM. ParkK. PezeshkianS. SherzaiD. SherzaiD. Micronutrients and risk of Parkinson’s disease.Gerontol. Geriatr. Med.20162233372141664428610.1177/233372141664428628138496
     [Google Scholar]
  9. WuF. XuK. LiuL. ZhangK. XiaL. ZhangM. TengC. TongH. HeY. XueY. ZhangH. ChenD. HuA. Vitamin B12 enhances nerve repair and improves functional recovery after traumatic brain injury by inhibiting ER stress-induced neuron injury.Front. Pharmacol.20191040610.3389/fphar.2019.0040631105562
     [Google Scholar]
  10. KookS-Y. LeeK-M. KimY. ChaM-Y. KangS. BaikS.H. LeeH. ParkR. Mook-JungI. High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice.Cell Death Dis.201452e108310.1038/cddis.2014.2624577081
     [Google Scholar]
  11. PaleologosM. DimmingR.G. LazarusR. Cohort study of vitamin C intake and cognitive impairment.Am J Epidemiol.19981481455010.1093/oxfordjournals.aje.a009559.
     [Google Scholar]
  12. DursunE. AlaylıoğluM. BilgiçB. HanağasıH. LohmannE. AtasoyI.L. CandaşE. ArazÖ.S. ÖnalB. GürvitH. YılmazerS. Gezen-AkD. Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer’s disease patients.Neurol. Sci.201637101633164310.1007/s10072‑016‑2647‑127357856
     [Google Scholar]
  13. HiraS. SaleemU. AnwarF. SohailM.F. RazaZ. AhmadB. β-Carotene: A Natural compound improves cognitive impairment and oxidative stress in a mouse model of streptozotocin-induced Alzheimer’s disease.Biomolecules20199944110.3390/biom909044131480727
     [Google Scholar]
  14. TakasakiJ. OnoK. YoshiikeY. HirohataM. IkedaT. MorinagaA. TakashimaA. YamadaM. Vitamin A has anti-oligomerization effects on amyloid-β in vitro .J. Alzheimers Dis.201127227128010.3233/JAD‑2011‑11045521811022
     [Google Scholar]
  15. MurakamiK. MurataN. OzawaY. KinoshitaN. IrieK. ShirasawaT. ShimizuT. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer’s disease.J. Alzheimers Dis.201126171810.3233/JAD‑2011‑10197121558647
     [Google Scholar]
  16. ZhaoX. ZhangM. LiC. JiangX. SuY. ZhangY. Benefits of vitamins in the treatment of Parkinson's disease.Oxid Med Cell Longev.20192019942686710.1155/2019/9426867
     [Google Scholar]
  17. OlajideO.J. YawsonE.O. GbadamosiI.T. ArogundadeT.T. LambeE. ObasiK. LawalI.T. IbrahimA. OgunrinolaK.Y. Ascorbic acid ameliorates behavioural deficits and neuropathological alterations in rat model of Alzheimer’s disease.Environ. Toxicol. Pharmacol.20175020021110.1016/j.etap.2017.02.01028192749
     [Google Scholar]
  18. SilS. GhoshT. GuptaP. GhoshR. KabirS.N. RoyA. Dual role of Vitamin C on the neuroinflammation mediated neurodegeneration and memory impairments in colchicine induced rat model of Alzheimer disease.J. Mol. Neurosci.201660442143510.1007/s12031‑016‑0817‑527665568
     [Google Scholar]
  19. YaminiP. RayR.S. ChopraK. Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer’s disease.Inflammopharmacology2018261395510.1007/s10787‑017‑0372‑x28702935
     [Google Scholar]
  20. BrionesT.L. DarwishH. Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden.J. Neuroinflammation20129172710.1186/1742‑2094‑9‑24423098125
     [Google Scholar]
  21. Saad El-DinS. RashedL. MedhatE. EmadA.B. DesokyB.A. Mohammed ShamsEldeenA. AbdelgwadM. Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer’s disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways.Steroids202015610858610.1016/j.steroids.2020.10858631982424
     [Google Scholar]
  22. ErtilavE. BarcinN.E. OzdemS. Comparison of serum free and bioavailable 25-Hydroxyvitamin D levels in Alzheimer’s disease and healthy control patients.Lab. Med.202152321922510.1093/labmed/lmaa06632893866
     [Google Scholar]
  23. AliA. ShahS.A. ZamanN. UddinM.N. KhanW. AliA. RiazM. KamilA. Vitamin D exerts neuroprotection via SIRT1/nrf-2/ NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice.Neurochem. Int.202114210489310.1016/j.neuint.2020.10489333159979
     [Google Scholar]
  24. GugliandoloA. BramantiP. MazzonE. Role of vitamin E in the treatment of Alzheimer's disease: Evidence from animal models.Int J Mol Sci.20171812250410.3390/ijms18122504
     [Google Scholar]
  25. BaroniL. BonettoC. RizzoG. BertolaC. CaberlottoL. BazzerlaG. Association between cognitive impairment and Vitamin B12, folate, and homocysteine status in elderly adults: A retrospective study.J. Alzheimers Dis.201970244345310.3233/JAD‑19024931177227
     [Google Scholar]
  26. YuL. ChenY. WangW. XiaoZ. HongY. Multi-Vitamin B supplementation reverses hypoxia-induced tau hyperphosphorylation and improves memory function in adult mice.J. Alzheimers Dis.201654129730610.3233/JAD‑16032927497480
     [Google Scholar]
  27. HuangJ.K. JarjourA.A. Nait OumesmarB. KerninonC. WilliamsA. KrezelW. KagechikaH. BauerJ. ZhaoC. EvercoorenA.B-V. ChambonP. ffrench-ConstantC. FranklinR.J.M. Retinoid X receptor gamma signaling accelerates CNS remyelination.Nat. Neurosci.2011141455310.1038/nn.270221131950
     [Google Scholar]
  28. de WildeM.C. VellasB. GiraultE. YavuzA.C. SijbenJ.W. Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses.Alzheimers Dement (N Y)20173341643110.1016/j.trci.2017.06.002
     [Google Scholar]
  29. KurutasE.B. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: Current state.Nutr J.20161517110.1186/s12937‑016‑0186‑5
     [Google Scholar]
  30. BhattiA.B. UsmanM. AliF. SattiS.A. Vitamin supplementation as an adjuvant treatment for Alzheimer’s disease.J Clin Diagn Res2016108OE071110.7860/JCDR/2016/20273.8261
     [Google Scholar]
  31. Lopes Da SilvaS. VellasB. ElemansS. LuchsingerJ. KamphuisP. YaffeK. SijbenJ. GroenendijkM. StijnenT. Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis.Alzheimers Dement201410448550210.1016/j.jalz.2013.05.1771
     [Google Scholar]
  32. FoyC. PassmoreA. YoungI. LawsonJ. Plasma chain-breaking antioxidants in Alzheimer’s disease, vascular dementia and Parkinson’s disease.QJM1999921394510.1093/qjmed/92.1.39
     [Google Scholar]
  33. LloretA. EsteveD. MonllorP. Cervera-FerriA. LloretA. The effectiveness of vitamin E treatment in Alzheimer's disease.Int J Mol Sci.201920487910.3390/ijms20040879
     [Google Scholar]
  34. ZandiP.P. AnthonyJ.C. KhachaturianA.S. StoneS.V. GustafsonD. TschanzJ.T. NortonM.C. Welsh-BohmerK.A. BreitnerJ.C.S. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache county study.Arch Neurol.200461182810.1001/archneur.61.1.82.
     [Google Scholar]
  35. YuanC. FondellE. AscherioA. OkerekeO.I. GrodsteinF. HofmanA. WillettW.C. Long-term intake of dietary carotenoids is positively associated with late-life subjective cognitive function in a prospective study in US women.J Nutr.202015071871187910.1093/jn/nxaa087
     [Google Scholar]
  36. RefsumH. UelandP. M. Clinical significance of pharmacological modulation of homocysteine metabolism.Trends Pharmacol Sci.19901110411610.1016/0165‑6147(90)90148‑2.
     [Google Scholar]
  37. DouaudG. RefsumH. de JagerC.A. JacobyR. NicholsT.E. SmithS.M. SmithA.D. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment.Proc. Natl. Acad. Sci. USA2013110239523952810.1073/pnas.130181611023690582
     [Google Scholar]
  38. KumarA. PalfreyH.A. PathakR. KadowitzP.J. GettysT.W. MurthyS.N. The metabolism and significance of homocysteine in nutrition and health.Nutr Metab (Lond)2017147810.1186/s12986‑017‑0233‑z
     [Google Scholar]
  39. PriceB.R. WilcockD.M. WeekmanE.M. Hyperhomocysteinemia as a risk factor for vascular contributions to cognitive impairment and dementia.Front Aging Neurosci.20181035010.3389/fnagi.2018.00350
     [Google Scholar]
  40. de JagerC.A. OulhajA. JacobyR. RefsumH. SmithA.D. Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: A randomized controlled trial.Int. J. Geriatr. Psychiatry201227659260010.1002/gps.275821780182
     [Google Scholar]
  41. DurgaJ. Van BoxtelM.P.J. SchoutenG. KokF.J. JollesJ. KatanM.B. VerhoefP. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double blind, controlled trial.Lancet200736995572081610.1016/S0140‑6736(07)60109‑3.
     [Google Scholar]
  42. MorrisM. C. SchneiderJ. A. TangneyC. C. Thoughts on B-vitamins and dementia.J Alzheimers Dis.2006944293310.3233/JAD‑2006‑9409
     [Google Scholar]
  43. FordA.H. AlmeidaO.P. Effect of homocysteine lowering treatment on cognitive function: A systematic review and meta-analysis of randomized controlled trials.J. Alzheimers Dis.201229113314910.3233/JAD‑2012‑11173922232016
     [Google Scholar]
  44. FordA.H. AlmeidaO.P. Effect of vitamin B supplementation on cognitive function in the elderly: A systematic review and meta-analysis.Drugs Aging.201936541943410.1007/s40266‑019‑00649‑w
     [Google Scholar]
  45. WaldD.S. KasturiratneA. SimmondsM. Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials.Am. J. Med.20101236522527.e210.1016/j.amjmed.2010.01.01720569758
     [Google Scholar]
  46. SunY. LuC.J. ChienK.L. ChenS.T. ChenR.C. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer’s disease: A 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients.Clin. Ther.200729102204221410.1016/j.clinthera.2007.10.01218042476
     [Google Scholar]
  47. AisenP.S. SchneiderL.S. SanoM. Diaz-ArrastiaR. van DyckC.H. WeinerM.F. BottiglieriT. JinS. StokesK.T. ThomasR.G. ThalL.J. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: A randomized controlled trial.JAMA2008300151774178310.1001/jama.300.15.177418854539
     [Google Scholar]
  48. KwokT. WuY. LeeJ. LeeR. YungC.Y. ChoiG. LeeV. HarrisonJ. LamL. MokV. A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients.Clin. Nutr.20203982399240510.1016/j.clnu.2019.11.00531787369
     [Google Scholar]
  49. Van Der ZwaluwN.L. Dhonukshe-RuttenR.A.M. Van WijngaardenJ.P. Brouwer-BrolsmaE.M. Van De RestO. In 't VeldPH. EnnemanAW. van DijkSC. HamAC. SwartKM. van der VeldeN. van SchoorNM. van der CammenTJ. UitterlindenAG. LipsP. KesselsRP. de GrootLC. Results of 2-year vitamin B treatment on cognitive performance: Secondary data from an RCT.Neurology.2014832321586610.1212/WNL.0000000000001050.
     [Google Scholar]
  50. UlusuN.N. YilmazG. ErbayraktarZ. EvlıceA.T. ArasS. YenerG. AvciA. A Turkish 3-center study evaluation of serum folic acid and vitamin B12 levels in Alzheimer disease.Turk. J. Med. Sci.20154551159116610.3906/sag‑1406‑13626738362
     [Google Scholar]
  51. Lu'o'ngKv. NguyenLT. Role of thiamine in Alzheimer's disease.Am J Alzheimers Dis Other Demen.20112685889810.1177/1533317511432736
     [Google Scholar]
  52. RafieeS. AsadollahiK. RiaziG. AhmadianS. SabouryA.A. Vitamin B12 inhibits tau fibrillization via binding to cysteine residues of tau.ACS Chem. Neurosci.20178122676268210.1021/acschemneuro.7b0023028841372
     [Google Scholar]
  53. Lanyau-DomínguezY. Macías-MatosC. JesúsJ. MaríaG. Suárez-MedinaR. EugeniaM. Noriega-FernándezL. Guerra-HernándezM. Calvo-RodríguezM. Sánchez-GilY. García-KlibanskiM. Herrera-JavierD. Arocha-OriolC. Díaz-DomínguezM. Levels of vitamins and homocysteine in older adults with Alzheimer disease or mild cognitive impairment in Cuba.MEDICC Rev.2020224404710.37757/MR2020.V22.N4.1433295319
     [Google Scholar]
  54. ChenH. LiuS. JiL. WuT. JiY. ZhouY. ZhengM. ZhangM. XuW. HuangG. Folic acid supplementation mitigates Alzheimer’s disease by reducing inflammation: A Randomized controlled trial.Mediators Inflamm.2016201611010.1155/2016/591214627340344
     [Google Scholar]
  55. SohY. LeeD.H. WonC.W. Association between Vitamin B12 levels and cognitive function in the elderly Korean population.Medicine (Baltimore)20209930e2137110.1097/MD.000000000002137132791746
     [Google Scholar]
  56. DiasV. JunnE. MouradianM.M. The role of oxidative stress in Parkinson's disease.J Parkinsons Dis.2013344619110.3233/JPD‑130230
     [Google Scholar]
  57. HuangZ. LiuY. QiG. BrandD. ZhengS.G. Role of Vitamin A in the immune system.J Clin Med.20187925810.3390/jcm7090258
     [Google Scholar]
  58. Al TanouryZ. PiskunovA. Rochette-EglyC. Vitamin A and retinoid signaling: Genomic and nongenomic effects.J Lipid Res.201354717617510.1194/jlr.R030833
     [Google Scholar]
  59. LuongK.V.Q. NguyễnL.T.H. The beneficial role of thiamine in Parkinson disease.CNS Neurosci Ther.2013197461810.1111/cns.12078
     [Google Scholar]
  60. Franco-IborraS. VilaM. PerierC. Mitochondrial quality control in neurodegenerative diseases: Focus on Parkinson's disease and Huntington's disease.Front Neurosci.20181234210.3389/fnins.2018.00342
     [Google Scholar]
  61. MarashlyE.T. BohlegaS.A. Riboflavin has neuroprotective potential: Focus on Parkinson's disease and Migraine.Front Neurol.2017833310.3389/fneur.2017.00333
     [Google Scholar]
  62. ShahS.A. YoonG.H. KimH.O. KimM.O. Vitamin C neuroprotection against dose-dependent glutamate-induced neurodegeneration in the postnatal brain.Neurochem. Res.201540587588410.1007/s11064‑015‑1540‑225701025
     [Google Scholar]
  63. ParkH.A. EllisA.C. Dietary antioxidants and Parkinson's disease.Antioxidants (Basel).20209757010.3390/antiox9070570
     [Google Scholar]
  64. McAllisterC.J. ScowdenE.B. DewberryF.L. RichmanA. Renal failure secondary to massive infusion of vitamin C.JAMA198425213168410.1001/jama.1984.033501300160196471294
     [Google Scholar]
  65. WongK. ThomsonC. BaileyR.R. McDIARMIDS. GardnerJ. Acute oxalate nephropathy after a massive intravenous dose of vitamin C.Aust. N. Z. J. Med.199424441041110.1111/j.1445‑5994.1994.tb01477.x7980244
     [Google Scholar]
  66. GrossoG. BeiR. MistrettaA. MarventanoS. CalabreseG. MasuelliL. GigantiM.G. ModestiA. GalvanoF. GazzoloD. Effects of vitamin C on health: A review of evidence.Front Biosci (Landmark Ed).201318310172910.2741/4160.
     [Google Scholar]
  67. GoldJ. ShoaibA. GorthyG. GrossbergG.T. The role of vitamin D in cognitive disorders in older adults.Europ. Neurol. Rev.2018141414610.17925/USN.2018.14.1.41
     [Google Scholar]
  68. KunzlerA. RibeiroC.T. GasparottoJ. PetizL.L. da Rosa SilvaH.T. da SilvaJ.D.Jr BortolinR. de SouzaP.O. BarretoF. Espitia-PerezP. SchnorrC.E. SomensiN. MoreiraJ.C.F. GelainD.P. The effects of retinol oral supplementation in 6-hydroxydopamine dopaminergic denervation model in Wistar rats.Neurochem. Int.2019125253410.1016/j.neuint.2019.02.00230739037
     [Google Scholar]
  69. PremaA. JanakiramanU. ManivasagamT. Justin ThenmozhiA. Neuroprotective effect of lycopene against MPTP induced experimental Parkinson’s disease in mice.Neurosci. Lett.2015599121910.1016/j.neulet.2015.05.02425980996
     [Google Scholar]
  70. KaurH. ChauhanS. SandhirR. Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson’s disease.Neurochem. Res.20113681435144310.1007/s11064‑011‑0469‑321484267
     [Google Scholar]
  71. TranH.H. DangS.N.A. NguyenT.T. HuynhA.M. DaoL.M. KameiK. YamaguchiM. DangT.T.P. Drosophila ubiquitin c-terminal hydrolase knockdown model of Parkinson’s disease.Sci. Rep.201881446810.1038/s41598‑018‑22804‑w29535397
     [Google Scholar]
  72. Man AnhH. LinhD.M. My DungV. Thi Phuong ThaoD. Evaluating dose- and time-dependent effects of vitamin c treatment on a Parkinson’s disease fly model.Parkinsons Dis.2019201911410.1155/2019/972054630719278
     [Google Scholar]
  73. LimaL.A.R. LopesM.J.P. CostaR.O. LimaF.A.V. NevesK.R.T. CalouI.B.F. AndradeG.M. VianaG.S.B. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.J. Neuroinflammation201815124910.1186/s12974‑018‑1266‑630170624
     [Google Scholar]
  74. SchirinziT. MartellaG. ImbrianiP. Di LazzaroG. FrancoD. ColonaV.L. AlwardatM. Sinibaldi SalimeiP. MercuriN.B. PierantozziM. PisaniA. Dietary vitamin E as a protective factor for Parkinson’s disease: Clinical and experimental evidence.Front. Neurol.20191014810.3389/fneur.2019.0014830863359
     [Google Scholar]
  75. UedaS. SakakibaraS. NakadateK. NodaT. ShinodaM. JoyceJ.N. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.Neurosci. Lett.2005380325225610.1016/j.neulet.2005.01.05315862896
     [Google Scholar]
  76. Lud CadetJ. KatzM. Jackson-LewisV. FahnS. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidence.Brain Res.198947611010.1016/0006‑8993(89)91530‑8.
     [Google Scholar]
  77. RoghaniM. BehzadiG. Neuroprotective effect of vitamin E on the early model of Parkinson’s disease in rat: Behavioral and histochemical evidence.Brain Res.2001892121121710.1016/S0006‑8993(00)03296‑011172767
     [Google Scholar]
  78. HeimC. KolasiewiczW. KurzT. SontagK.H. Behavioral alterations after unilateral 6-hydroxydopamine lesions of the striatum. Effect of alpha-tocopherol.Pol. J. Pharmacol.200153543544811990061
     [Google Scholar]
  79. CraftN.E. HaitemaT.B. GarnettK.M. FitchK.A. DoreyC.K. Carotenoid, tocopherol, and retinol concentrations in elderly human brain.J. Nutr. Health Aging20048315616215129301
     [Google Scholar]
  80. YingA.F. KhanS. WuY. JinA. WongA.S.Y. TanE.K. YuanJ.M. KohW.P. TanL.C.S. Dietary antioxidants and risk of Parkinson’s disease in the Singapore Chinese health study.Mov. Disord.202035101765177310.1002/mds.2817332643256
     [Google Scholar]
  81. DietikerC. KimS. ZhangY. ChristineC. W. Characterization of Vitamin B12 supplementation and correlation with clinical outcomes in a large longitudinal study of early Parkinson's disease.J Mov Disord.2019122919610.14802/jmd.18049
     [Google Scholar]
  82. ShenL. Associations between B vitamins and Parkinson’s disease.Nutrients2015797197720810.3390/nu709533326343714
     [Google Scholar]
  83. DrouinG. GodinJ-R. PagéB. The genetics of vitamin C loss in vertebrates.Curr Genomics.2011125371810.2174/138920211796429736.
     [Google Scholar]
  84. HåglinL. JohanssonI. ForsgrenL. BäckmanL. Intake of vitamin B before onset of Parkinson’s disease and atypical parkinsonism and olfactory function at the time of diagnosis.Eur. J. Clin. Nutr.20177119710210.1038/ejcn.2016.18127703161
     [Google Scholar]
  85. NagayamaH. HamamotoM. UedaM. NitoC. YamaguchiH. KatayamaY. The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease.Clin Neuropharmacol.2004276270310.1097/01.wnf.0000150865.21759.bc
     [Google Scholar]
  86. OzturkE.A. GundogduI. TonukB. KocerB.G. TombakY. ComogluS. CakciA. Bone mass and vitamin D levels in Parkinson’s disease: Is there any difference between genders?J. Phys. Ther Sci.20162882204910.1589/jpts.28.2204
     [Google Scholar]
  87. SunyeczJ. The use of calcium and vitamin D in the management of osteoporosis.Ther. Clin. Risk Manag.20084482783610.2147/TCRM.S355219209265
     [Google Scholar]
  88. LuoX. OuR. DuttaR. TianY. XiongH. ShangH. Association between serum Vitamin D levels and Parkinson’s disease: A systematic review and meta-analysis.Front. Neurol.2018990910.3389/fneur.2018.0090930483205
     [Google Scholar]
  89. LuthraN.S. KimS. ZhangY. ChristineC.W. Characterization of vitamin D supplementation and clinical outcomes in a large cohort of early Parkinson’s disease.J. Clin. Mov. Disord.201851710.1186/s40734‑018‑0074‑630397507
     [Google Scholar]
  90. VatasseryG.T. FahnS. KuskowskiM.A. Alpha tocopherol in CSF of subjects taking high‐dose vitamin E in the DATATOP study.Neurology19985061900190210.1212/WNL.50.6.19009633757
     [Google Scholar]
  91. PhamD.Q. PlakogiannisR. Vitamin E supplementation in Alzheimer’s disease, Parkinson’s disease, tardive dyskinesia, and cataract: Part 2.Ann. Pharmacother.200539122065207210.1345/aph.1G27116288072
     [Google Scholar]
  92. ConradG.D. Is Ginkgo biloba and/or a Multivitamin-multimineral supplement a therapeutic option for Parkinson’s disease? A case report.Glob. Adv. Health Med.201434434410.7453/gahmj.2013.09625105077
     [Google Scholar]
  93. SidhuA. DiwanV. KaurH. BhatejaD. SinghC.K. SharmaS. PadiS.S.V. Nicotinamide reverses behavioral impairments and provides neuroprotection in 3˗nitropropionic acid induced animal model ofHuntington’s disease: Implication of oxidative stress˗ poly(ADP˗ ribose) polymerase pathway.Metab. Brain Dis.20183361911192110.1007/s11011‑018‑0297‑030054774
     [Google Scholar]
  94. Fort MolnárM. TörökR. SzalárdyL. SümegiE. VécseiL. KlivényiP. High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice.Acta Neurobiol Exp (Wars)20167631768110.21307/ane‑2017‑017.
     [Google Scholar]
  95. KašparováS. SumbalováZ. BystrickýP. KucharskáJ. LiptajT. MlynárikV. GvozdjákováA. Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington’s disease.Neurochem. Int.2006482939910.1016/j.neuint.2005.09.00216290265
     [Google Scholar]
  96. PeyserC.E. FolsteinM. ChaseG.A. StarksteinS. BrandtJ. CockrellJ.R. BylsmaF. CoyleJ.T. McHughP.R. FolsteinS.E. Trial of d-alpha-tocopherol in Huntington’s disease.Am. J. Psychiatry1995152121771177510.1176/ajp.152.12.17718526244
     [Google Scholar]
  97. BabriS. MehrvashF. MohaddesG. HatamiH. MirzaieF. Effect of intrahippocampal administration of vitamin C and progesterone on learning in a model of multiple sclerosis in rats.Adv. Pharm. Bull.201551838710.5681/apb.2015.01125789223
     [Google Scholar]
  98. AdzemovicM.Z. ZeitelhoferM. HochmeisterS. GustafssonS.A. JagodicM. Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage.Exp. Neurol.2013249394810.1016/j.expneurol.2013.08.00223954214
     [Google Scholar]
  99. MillerE.D. DziedzicA. Saluk-BijakJ. BijakM. A review of various antioxidant compounds and their potential utility as complementary therapy in multiple sclerosis.Nutrients.2019117152810.3390/nu11071528
     [Google Scholar]
  100. SintzelM.B. RamettaM. RederA.T. Vitamin D and multiple sclerosis: A comprehensive review.Neurol Ther.201871598510.1007/s40120‑017‑0086‑4
     [Google Scholar]
  101. TorkildsenØ. Løken-AmsrudK.I. WergelandS. MyhrK.M. HolmøyT. Fat-soluble vitamins as disease modulators in multiple sclerosis.Acta Neurol. Scand.2013127196162310.1111/ane.1204523190287
     [Google Scholar]
  102. RuniaT.F. HopW.C.J. de RijkeY.B. HintzenR.Q. Vitamin A is not associated with exacerbations in multiple sclerosis.Mult. Scler. Relat. Disord.201431343910.1016/j.msard.2013.06.01125877971
     [Google Scholar]
  103. NajafiM.R. ShaygannajadV. MirpourianM. GholamrezaeiA. Vitamin B(12) deficiency and multiple sclerosis; Is there any association?Int. J. Prev. Med.20123428628922624086
     [Google Scholar]
  104. CostantiniA. NappoA. PalaM.I. ZapponeA. High dose thiamine improves fatigue in multiple sclerosis.BMJ Case Rep.20132013bcr201300914410.1136/bcr‑2013‑00914423861280
     [Google Scholar]
  105. BeslerH.T. OmoǧluS. OkuZ. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis.Nutr Neurosci.2002532152010.1080/10284150290029205
     [Google Scholar]
  106. PolachiniC.R.N. SpanevelloR.M. ZaniniD. BaldissarelliJ. PereiraL.B. SchetingerM.R.C. da CruzI.B.M. AssmannC.E. BagatiniM.D. MorschV.M. Evaluation of delta-aminolevulinic dehydratase activity, oxidative stress biomarkers, and vitamin D levels in patients with multiple sclerosis.Neurotox. Res.201629223024210.1007/s12640‑015‑9584‑226690779
     [Google Scholar]
  107. TavazziB. BatocchiA.P. AmoriniA.M. NocitiV. D’UrsoS. LongoS. GullottaS. PicardiM. LazzarinoG. Serum metabolic profile in multiple sclerosis patients.Mult. Scler. Int.201120111810.1155/2011/16715622096628
     [Google Scholar]
  108. MungerK.L. ÅivoJ. HongellK. Soilu-HänninenM. SurcelH.M. AscherioA. Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish Maternity Cohort.JAMA Neurol.201673551551910.1001/jamaneurol.2015.480026953778
     [Google Scholar]
  109. SmoldersJ. DamoiseauxJ. MenheereP. HuppertsR. Vitamin D as an immune modulator in multiple sclerosis, A review.J Neuroimmunol.20081941-271710.1016/j.jneuroim.2007.11.014
     [Google Scholar]
  110. MüllerT. LohseL. BlodauA. FrommholzK. Vitamin D rise enhances blood perfusion in patients with multiple sclerosis.J. Neural Transm. (Vienna)2019126121631163610.1007/s00702‑019‑02093‑x31620863
     [Google Scholar]
  111. Hernández-PedroN.Y. Espinosa-RamirezG. De La CruzV.P. PinedaB. SoteloJ. Initial immunopathogenesis of multiple sclerosis: Innate immune response.Clin Dev Immunol.2013201341346510.1155/2013/413465
     [Google Scholar]
  112. LongKv. NguyễnLT. Roles of vitamin D in amyotrophic lateral sclerosis: Possible genetic and cellular signaling mechanisms.Mol Brain.201361610.1186/1756‑6606‑6‑16.
     [Google Scholar]
  113. CorteseR. D'ErricoE. IntronaA. SchirosiG. ScarafinoA. DistasoE. SimoneI. Vitamin D levels in serum of amyotrophic lateral sclerosis patients.Neurology20158414_supplementP2-06910.1212/WNL.84.14_supplement.P2.069.
     [Google Scholar]
  114. CamuW. TremblierB. PlassotC. AlphanderyS. SalsacC. PageotN. Juntas-MoralesR. ScampsF. DauresJ.P. RaoulC. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis.Neurobiol. Aging20143551198120510.1016/j.neurobiolaging.2013.11.00524378089
     [Google Scholar]
  115. GianforcaroA. SolomonJ.A. HamadehM.J. Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females.PLoS One201382e3024310.1371/journal.pone.003024323405058
     [Google Scholar]
  116. GianforcaroA. HamadehM.J. Dietary vitamin D3 supplementation at 10× the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study.CNS Neurosci. Ther.201218754755710.1111/j.1755‑5949.2012.00316.x22591278
     [Google Scholar]
  117. SolomonJ.A. GianforcaroA. HamadehM.J. Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis.PLoS One2011612e2935410.1371/journal.pone.002935422216257
     [Google Scholar]
  118. LibonatiL. OnestiE. GoriM.C. CeccantiM. CambieriC. FabbriA. FrascaV. InghilleriM. Vitamin D in amyotrophic lateral sclerosis.Funct. Neurol.2017321354010.11138/FNeur/2017.32.1.03528380322
     [Google Scholar]
  119. AscherioA. WeisskopfM.G. O’ReillyE.J. JacobsE.J. McCulloughM.L. CalleE.E. CudkowiczM. ThunM.J. Vitamin E intake and risk of amyotrophic lateral sclerosis.Ann. Neurol.200557110411010.1002/ana.2031615529299
     [Google Scholar]
  120. ChiricostaL. GugliandoloA. TardioloG. BramantiP. MazzonE. Transcriptomic analysis of mapk signaling in NSC-34 motor neurons treated with Vitamin E.Nutrients2019115108110.3390/nu1105108131096690
     [Google Scholar]
/content/journals/cn/10.2174/011570159X327677240902105443
Loading
Exploration of the Role of Vitamins in Preventing Neurodegenerative Diseases: Comprehensive Review on Preclinical and Clinical Findings
Curr. Neuropharmacol. 23, 547 (2025); https://doi.org/10.2174/011570159X327677240902105443
/content/journals/cn/10.2174/011570159X327677240902105443
/content/journals/cn/10.2174/011570159X327677240902105443
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Alzheimer's disease; amyotrophic lateral sclerosis; Huntington's disease; multiple sclerosis; Neurodegenerative diseases; Parkinson's disease; vitamin

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test